Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2005
06/01/2005EP1536011A1 Preventives/remedies for neurodegenerative diseases
06/01/2005EP1536009A1 Hla-a24-restricted cancer antigen peptide
06/01/2005EP1536006A1 Cancer antigens and utilization thereof
06/01/2005EP1535928A2 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
06/01/2005EP1535628A2 HBV/HCV virus-like particle
06/01/2005EP1535627A1 Recombinant bcg vaccine
06/01/2005EP1535626A2 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
06/01/2005EP1535067A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE
06/01/2005EP1534852A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
06/01/2005EP1534846A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines
06/01/2005EP1534845A1 Generation of recombinant influenza virus using baculovirus delivery vector
06/01/2005EP1534837A2 Apicomplexan pathways, inhibitiors, and drug delivery
06/01/2005EP1534836A1 Mutant forms of meningococcal adp-ribosylating toxin
06/01/2005EP1534827A1 Method for generating monoclonal antibodies
06/01/2005EP1534824A1 Streptococccus suis surface proteins, ornithine carbamolytransferase and arginine deiminase, expressed under stress conditions
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534750A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
06/01/2005EP1534742A1 Compositions and methods for treatment and prophylaxis of infections caused by gram positive bacteria
06/01/2005EP1534736A2 Nogo receptor antagonists
06/01/2005EP1534730A2 Modified transferin-antibody fusion proteins
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534512A1 Coated particles, methods of making and using
06/01/2005EP1534344A2 Viruses and virus-like particles for multiple antigen and target display
06/01/2005EP1534337A2 Ptk7 protein involvement in carcinoma
06/01/2005EP1534335A2 Fcgammariib-specific antibodies and methods of use thereof
06/01/2005EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534331A2 Membrane associated tumor endothelium markers
06/01/2005EP1534330A1 Whole bacterial cells as immune modulator
06/01/2005EP1534329A2 Vaccine comprising il-13 and an adjuvant
06/01/2005EP1534328A2 Protective antigens for the control of ixodes species infestations
06/01/2005EP1534327A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
06/01/2005EP1534326A2 Improved bacterial outer membrane vesicles
06/01/2005EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof
06/01/2005EP1534323A2 Il-14 vaccine for the treatment of asthma and atopic disorders
06/01/2005EP1534317A2 N-terminally truncated galectin-3 and antibodies for treating cancer
06/01/2005EP1534315A2 Increasing of the resorption of substances via skin and mucous membranes
06/01/2005EP1534312A2 Intrathecal and intratumoral superantigens to treat malignant disease
06/01/2005EP1534310A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
06/01/2005EP1534284A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
06/01/2005EP1534242A2 Buccal, polar or non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
06/01/2005EP1534236A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
06/01/2005EP1218064B1 COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASEs CONTAINING A COMPOUND WHICH INHIBITS ICAM-LFA-1 INTERACTION AND A COMPOUND WHICH INHIBITS CD40-CD40 LIGAND INTERACTION
06/01/2005EP1206189B1 Rotavirus vaccine formulations
06/01/2005EP1171160B1 Method and means for treating post-polio syndrome
06/01/2005EP1157041B1 Antibodies for cancer therapy and diagnosis
06/01/2005EP1119346B1 Rna cancer vaccine and methods for its use
06/01/2005EP1066376B1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
06/01/2005EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
06/01/2005EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells
06/01/2005EP0792358B1 A polynucleotide tuberculosis vaccine
06/01/2005CN1622992A Synthetic peptides and methods for treating cancer invasion and metastasis
06/01/2005CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
06/01/2005CN1622829A Solidified tissue immunological adjuvant
06/01/2005CN1622828A Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/01/2005CN1622754A Novel immune effect compound
06/01/2005CN1621526A Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof
06/01/2005CN1621418A Recombinant targeted toxin against HIV-1
06/01/2005CN1621417A Antibody against SARS-CoV IgY and its preparing method
06/01/2005CN1621415A Immunoglobulin antibody against SARS-CoV and its preparing method
06/01/2005CN1621414A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof
06/01/2005CN1621091A Intestine targeted formulation of PEGylated rotavirus and its synthesizing method
06/01/2005CN1621090A Oral freeze dried formulation of specific yelk immunoglobulin and its preparation method and usage
06/01/2005CN1621089A Method for removing endotoxin from influenza vaccine formulation
06/01/2005CN1621088A Method for removing endotoxin from influenza vaccine formulation
06/01/2005CN1620886A Ice-cream for preventing decayed tooth
06/01/2005CN1204258C Component of bromelain
06/01/2005CN1204253C Neisseria lactoferrin binding protein
06/01/2005CN1204251C Process for preparing VP2 protein from master host protective antigen (VP2) gene of infections burse disease virus (IBDV) and its gene engineering
06/01/2005CN1204247C Recombined adenovirus and its use in curing myocardial ischemia
06/01/2005CN1204146C Method for preparing alpha-fetoglobulin transspecific factor
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/31/2005US6900299 Antisense oligonucleotide inhalant for prevention and treatment of respiratory system disorders; viricides
05/31/2005US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer
05/31/2005US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors
05/31/2005US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
05/31/2005US6900024 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
05/31/2005US6900010 Taking a culture of recombinant cells comprises a reporter sequence; contacting cell culture with a sample containing HIV; adding a tester agent to the cell culture; and detecting change in a level of expression of reporter gene in culture
05/31/2005US6899885 74-kilodalton outer membrane protein from Moraxella catarrhalis
05/31/2005US6899884 Vaccine against mumps containing a jeryl-lynn virus strain
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/31/2005US6899880 Polypeptide vaccine; induce immunology response
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/31/2005US6899863 Method for preparing membrane vesicles
05/31/2005CA2267157C Cancer immunotherapy using tumor cells combined with mixed lymphocytes
05/26/2005WO2005047483A2 Renta: an hiv immunogen and uses thereof
05/26/2005WO2005047476A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
05/26/2005WO2005047461A2 Polypeptide display libraries and methods of making and using thereof
05/26/2005WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof
05/26/2005WO2005047458A2 Modified recombinant vaccina viruses and other microorganisms, uses thereof
05/26/2005WO2005047328A2 Antibodies against secretoryleukocyte protease inhibitor
05/26/2005WO2005047315A2 Optimized expression of hpv 58 l1 in yeast
05/26/2005WO2005047309A2 Prophylactic and therapeutic monoclonal antibodies
05/26/2005WO2005046723A1 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin
05/26/2005WO2005046722A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
05/26/2005WO2005046721A2 Compositions for reducing bacterial carriage and cns invasion and methods of using same
05/26/2005WO2005046719A1 Vaccine and method for treatment of neurodegenerative diseases
05/26/2005WO2005046713A1 Proteins involved in quorum sensing
1 ... 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 ... 1823